BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37665745)

  • 1. Breast cancer risk assessment and risk distribution in 3,491 Slovenian women invited for screening at the age of 50; a population-based cross-sectional study.
    Jarm K; Zadnik V; Birk M; Vrhovec M; Hertl K; Klanecek Z; Studen A; Sval C; Krajc M
    Radiol Oncol; 2023 Sep; 57(3):337-347. PubMed ID: 37665745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening Strategy Modification Based on Personalized Breast Cancer Risk Stratification and its Implementation in the National Guidelines - Pilot Study.
    Krajc M; Gareth Evans D; Blatnik A; Lokar K; Žagar T; Tomšič S; Žgajnar J; Zadnik V
    Zdr Varst; 2020 Dec; 59(4):211-218. PubMed ID: 33133277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer risk prediction using Tyrer-Cuzick algorithm with an 18-SNPs polygenic risk score in a European population with below-average breast cancer incidence.
    Oblak T; Škerl P; Narang BJ; Blagus R; Krajc M; Novaković S; Žgajnar J
    Breast; 2023 Dec; 72():103590. PubMed ID: 37857130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the breast cancer risk distribution for women undergoing screening in British Columbia.
    Weisstock CR; Rajapakshe R; Bitgood C; McAvoy S; Gordon PB; Coldman AJ; Parker BA; Wilson C
    Cancer Prev Res (Phila); 2013 Oct; 6(10):1084-92. PubMed ID: 23963801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420).
    French DP; Astley S; Brentnall AR; Cuzick J; Dobrashian R; Duffy SW; Gorman LS; Harkness EF; Harrison F; Harvie M; Howell A; Jerrison A; Machin M; Maxwell AJ; McWilliams L; Payne K; Qureshi N; Ruane H; Sampson S; Stavrinos P; Thorpe E; Ulph F; van Staa T; Woof V; Evans DG
    BMC Cancer; 2020 Jun; 20(1):570. PubMed ID: 32552763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer risk based on adapted IBIS prediction model in Slovenian women aged 40-49 years - could it be better?
    Oblak T; Zadnik V; Krajc M; Lokar K; Zgajnar J
    Radiol Oncol; 2020 Jul; 54(3):335-340. PubMed ID: 32614783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the IBIS/Tyrer-Cuzick model of breast cancer risk by race and ethnicity in the Women's Health Initiative.
    Kurian AW; Hughes E; Simmons T; Bernhisel R; Probst B; Meek S; Caswell-Jin JL; John EM; Lanchbury JS; Slavin TP; Wagner S; Gutin A; Rohan TE; Shadyab AH; Manson JE; Lane D; Chlebowski RT; Stefanick ML
    Cancer; 2021 Oct; 127(20):3742-3750. PubMed ID: 34228814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An integrated breast cancer risk assessment and management model based on fuzzy cognitive maps.
    Subramanian J; Karmegam A; Papageorgiou E; Papandrianos N; Vasukie A
    Comput Methods Programs Biomed; 2015 Mar; 118(3):280-97. PubMed ID: 25697987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of Estimated Lifetime Breast Cancer Risk Among Women Undergoing Screening Mammography.
    Niell BL; Augusto B; McIntyre M; Conley CC; Gerke T; Roetzheim R; Garcia J; Vadaparampil ST
    AJR Am J Roentgenol; 2021 Jul; 217(1):48-55. PubMed ID: 33978450
    [No Abstract]   [Full Text] [Related]  

  • 11. A regional population-based hereditary breast cancer screening tool in Italy: First 5-year results.
    Cortesi L; Baldassarri B; Ferretti S; Razzaboni E; Bella M; Bucchi L; Canuti D; De Iaco P; De Santis G; Falcini F; Galli V; Godino L; Leoni M; Perrone AM; Pignatti M; Saguatti G; Santini D; Sassoli de'Bianchi P; Sebastiani F; Taffurelli M; Tazzioli G; Turchetti D; Zamagni C; Naldoni C
    Cancer Med; 2020 Apr; 9(7):2579-2589. PubMed ID: 32045136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420).
    Gareth Evans D; McWilliams L; Astley S; Brentnall AR; Cuzick J; Dobrashian R; Duffy SW; Gorman LS; Harkness EF; Harrison F; Harvie M; Jerrison A; Machin M; Maxwell AJ; Howell SJ; Wright SJ; Payne K; Qureshi N; Ruane H; Southworth J; Fox L; Bowers S; Hutchinson G; Thorpe E; Ulph F; Woof V; Howell A; French DP
    Br J Cancer; 2023 Jun; 128(11):2063-2071. PubMed ID: 37005486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compliance with screening recommendations according to breast cancer risk levels in Izmir, Turkey.
    Acikgoz A; Ergor G
    Asian Pac J Cancer Prev; 2013; 14(3):1737-42. PubMed ID: 23679266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.
    Evans DGR; Harkness EF; Brentnall AR; van Veen EM; Astley SM; Byers H; Sampson S; Southworth J; Stavrinos P; Howell SJ; Maxwell AJ; Howell A; Newman WG; Cuzick J
    Breast Cancer Res Treat; 2019 Jul; 176(1):141-148. PubMed ID: 30941651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying and Managing Patients with Elevated Breast Cancer Risk Presenting for Screening Mammography.
    Patel NJ; Mussallem DM; Maimone S
    Curr Probl Diagn Radiol; 2022; 51(6):838-841. PubMed ID: 35595586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the Cost of 3 Risk Prediction Strategies for Potential Use in the United Kingdom National Breast Screening Program.
    Wright SJ; Eden M; Ruane H; Byers H; Evans DG; Harvie M; Howell SJ; Howell A; French D; Payne K
    MDM Policy Pract; 2023; 8(1):23814683231171363. PubMed ID: 37152662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Race and Ethnicity-Adjusted Age Recommendation for Initiating Breast Cancer Screening.
    Chen T; Kharazmi E; Fallah M
    JAMA Netw Open; 2023 Apr; 6(4):e238893. PubMed ID: 37074714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on the Recommendations on Breast Cancer Screening by the Cancer Expert Working Group on Cancer Prevention and Screening.
    Tsang THF; Wong KH; Allen K; Chan KKL; Chan MCM; Chao DVK; Cheung AN; Fan CYM; Hui EP; Ip DKM; Lam KO; Law CK; Law WL; Loong HHF; Wong KH; Wong MCS; Yeung RMW; Ying ACH; Ho RKW
    Hong Kong Med J; 2022 Apr; 28(2):161-168. PubMed ID: 35400644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer screening knowledge among Hungarian women: a cross-sectional study.
    Reményi Kissné D; Gede N; Szakács Z; Kiss I
    BMC Womens Health; 2021 Feb; 21(1):69. PubMed ID: 33588813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of women aged 65-74 to invitation for screening for breast cancer by mammography: a pilot study in London, UK.
    Horton Taylor D; McPherson K; Parbhoo S; Perry N
    J Epidemiol Community Health; 1996 Feb; 50(1):77-80. PubMed ID: 8762359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.